Last reviewed · How we verify

NCT03441139: CRYO

Efficacy of Cryotherapy Combined or Not With Analgesics in Uncontrolled Painful Musculoskeletal Metastasis

Terminated NA Last updated 19 October 2021
What this trial tests

NA trial testing Cryotherapy + Medical analgesics in Musculoskeletal Pain in 18 participants. Terminated before completion.

Timeline
19 July 2018
Primary endpoint
30 May 2020
30 August 2020

Quick facts

Lead sponsorCentre Leon Berard
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment18
Start date19 July 2018
Primary completion30 May 2020
Estimated completion30 August 2020
Sites8 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Leon Berard — full company profile →

Who can join

18 and older, any sex, with Musculoskeletal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this trial is to compare the efficacy of 2 analgesic strategies, based on percutaneous cryotherapy plus medical supportive care versus medical supportive care alone in the treatment of cancer patients with painful musculoskeletal metastasis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Musculoskeletal Pain

Currently open trials in the same condition.

Other Centre Leon Berard trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03441139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing